Advances in treatment of diffuse large B-cell lymphoma

LI Li-juan;GUO Xiao-jia;ZHANG Lian-sheng

CLC Number:

LI Li-juan;GUO Xiao-jia;ZHANG Lian-sheng. Advances in treatment of diffuse large B-cell lymphoma[J]. Clinical Focus, 2014, 29(10): 1134-1139.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

[1]	Li Qing, Zhong Wen, Liu Siqiang, Chen Yusheng, Li Hongru. Meta-analysis of PD-1/PD-L1 inhibitors in the treatment of patients with non-small cell lung cancer having brain metastases [J]. Clinical Focus, 2022, 37(5): 400-405.
[2]	Ye Qian, Ling Zhi, Yin Xudong. Sarcopenia on immune checkpoint inhibitors in solid tumor patients with sarcopenia: A meta-analysis [J]. Clinical Focus, 2022, 37(10): 889-898.
[3]	Sun Mei1, Hou Xiaoxia2, Jin Shanquan1, Shen Feifei1, Cheng Hong1. LGI1 antibodyrelated limbic encephalitis: a case report and literature review [J]. Clinical Focus, 2019, 34(3): 273-275.
[4]	Mo Yijun1, Zhang Jianhua1, Yan Jun1, Lin Lina2. Treatment of advanced squamous nonsmall cell lung cancer with programmed cell death ligand 1 inhibitors: a report of two cases and literature review [J]. Clinical Focus, 2019, 34(3): 237-243.
[5]	WEI Hui. Treatment of acute lymphoblastic leukemia [J]. Clinical Focus, 2014, 29(10): 1100-1103.

PDF (PC)